Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients.

Toan NL, Sy BT, Song le H, Luong HV, Binh NT, Binh VQ, Kandolf R, Velavan TP, Kremsner PG, Bock CT.

BMC Infect Dis. 2013 Aug 15;13:375. doi: 10.1186/1471-2334-13-375.

2.

The effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian children.

Duedu KO, Sagoe KW, Ayeh-Kumi PF, Affrim RB, Adiku T.

Asian Pac J Trop Biomed. 2013 Feb;3(2):129-39. doi: 10.1016/S2221-1691(13)60037-4.

3.

Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.

Jain P, Jain A, Prakash S, Khan DN, Singh DD, Kumar A, Moulik NR, Chandra T.

J Med Virol. 2015 Feb;87(2):303-9. doi: 10.1002/jmv.24028. Epub 2014 Aug 2.

PMID:
25087946
4.

Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.

Slavov SN, Haddad SK, Silva-Pinto AC, Amarilla AA, Alfonso HL, Aquino VH, Covas DT.

J Med Virol. 2012 Oct;84(10):1652-65. doi: 10.1002/jmv.23358.

PMID:
22930515
5.

Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities.

da Costa AC, Bendit I, de Oliveira AC, Kallas EG, Sabino EC, Sanabani SS.

Clin Microbiol Infect. 2013 Jan;19(1):E31-43. doi: 10.1111/1469-0691.12058. Epub 2012 Nov 20.

6.

Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.

Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S.

Clin Infect Dis. 2009 Dec 1;49(11):1660-6. doi: 10.1086/648074.

7.

Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.

Opaleye OO, Fagbami AH, Lalremruata A, Kun JF.

J Med Virol. 2011 Apr;83(4):710-6. doi: 10.1002/jmv.22008.

PMID:
21328387
8.

Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection.

Ingrassia F, Gadaleta A, Maggi P, Pastore G.

BMC Infect Dis. 2010 Apr 1;10:87. doi: 10.1186/1471-2334-10-87.

9.

Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.

Grabarczyk P, Kalińska A, Kara M, Wieczorek R, Ejduk A, Sulkowska E, Gołębiowska-Staroszczyk S, Matysiak M, Baylis SA, Brojer E.

J Med Virol. 2011 Jan;83(1):142-9. doi: 10.1002/jmv.21947.

PMID:
21108352
10.

Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.

Oh DJ, Lee YL, Kang JW, Kwon SY, Cho NS.

Korean J Lab Med. 2010 Feb;30(1):58-64. doi: 10.3343/kjlm.2010.30.1.58.

11.

Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.

Sakata H, Matsubayashi K, Ihara H, Sato S, Kato T, Wakisaka A, Tadokoro K, Yu MY, Baylis SA, Ikeda H, Takamoto S.

Transfusion. 2013 Oct;53(10 Pt 2):2556-66. doi: 10.1111/j.1537-2995.2012.03949.x. Epub 2012 Nov 12.

PMID:
23145866
12.

Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.

Plentz A, Würdinger M, Kudlich M, Modrow S.

J Clin Virol. 2013 Oct;58(2):443-8. doi: 10.1016/j.jcv.2013.07.007. Epub 2013 Jul 31.

PMID:
23916377
13.

Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders.

Jitschin R, Peters O, Plentz A, Turowski P, Segerer H, Modrow S.

Clin Microbiol Infect. 2011 Sep;17(9):1336-42. doi: 10.1111/j.1469-0691.2010.03355.x. Epub 2011 Mar 3.

14.

Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathies.

Slavov SN, Kashima S, Silva-Pinto AC, Covas DT.

Can J Microbiol. 2012 Feb;58(2):200-5. doi: 10.1139/w11-119. Epub 2012 Jan 26.

PMID:
22280886
15.

Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.

Koppelman MH, Rood IG, Fryer JF, Baylis SA, Cuypers HT.

Vox Sang. 2007 Oct;93(3):208-15.

PMID:
17845257
16.

Adaptive immune responses against parvovirus B19 in patients with myocardial disease.

Lindner J, Noutsias M, Lassner D, Wenzel J, Schultheiss HP, Kuehl U, Modrow S.

J Clin Virol. 2009 Jan;44(1):27-32. doi: 10.1016/j.jcv.2008.09.007. Epub 2008 Nov 5.

PMID:
18980860
17.

Plasmodium falciparum malaria with coexisting parvovirus B19 infection.

Urganci N, Arapoglu M, Kayaalp N.

Indian Pediatr. 2003 Apr;40(4):369-70. No abstract available.

PMID:
12736416
18.

Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S.

J Med Virol. 2005 Jan;75(1):161-9.

PMID:
15543575
19.

Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.

Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ.

J Gastroenterol Hepatol. 2005 May;20(5):733-8.

PMID:
15853987
20.

Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.

Ennis O, Corcoran A, Kavanagh K, Mahon BP, Doyle S.

J Clin Virol. 2001 Aug;22(1):55-60.

PMID:
11418353
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk